Hunan Jingfeng Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Jingfeng Pharmaceutical Co Ltd with three other
companies in this sector in China:
SSY Group Ltd
sales of 2.66 billion Chinese Renmimbi [US$392.81 million]
of which 96%
was Intravenous Infusion Solution and Others),
Anhui Fengyuan Pharmaceutical
(2.58 billion Chinese Renmimbi [US$380.99 million]
of which 58%
was Medicine Retail Circulation), and
Guizhou Bailing Group Pharmaceutical Company Limited
(2.59 billion Chinese Renmimbi [US$383.02 million]
of which 91%
Hunan Jingfeng Pharmaceutical Co Ltd reported sales of 2.58 billion Chinese Renmimbi (US$381.81 million)
December of 2017.
decrease of 2.1%
versus 2016, when the company's sales were 2.64 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 76.7% decline
in Other Operation, from 14.94 million Chinese Renmimbi to 3.47 million Chinese Renmimbi.
There were also decreases in sales in
Medicine Manufacturing (down 2.3% to 2.50 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Medical Services (up 18.5% to 82.84 million Chinese Renmimbi)